The CRX Gene Cone-Rod Dystrophy Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the CRX gene, which are linked to Cone-Rod Dystrophy Type 2, a rare genetic disorder. This condition affects the retina and leads to the progressive loss of vision, starting with color vision and night vision difficulties, eventually progressing to a loss of peripheral and central vision. Early detection through this genetic test can be crucial for managing the condition and exploring potential treatment options. The test is priced at 4400 AED and involves a comprehensive analysis of the CRX gene to pinpoint any genetic abnormalities. By opting for this test at DNA Labs UAE, individuals can gain valuable insights into their genetic makeup, enabling them to take proactive steps towards managing their ocular health.
The POC1B gene cone-rod dystrophy type 20 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the POC1B gene that are associated with cone-rod dystrophy type 20. Cone-rod dystrophy is a group of inherited eye disorders that affect the retina's photoreceptor cells, leading to a progressive loss of vision. The POC1B gene plays a crucial role in the structure and function of these cells, and mutations can result in the early onset of vision problems, including loss of visual acuity, color vision defects, and sensitivity to light.
The test is conducted through a blood sample or cheek swab, which is then analyzed for specific genetic variations indicative of the condition. This test is particularly important for individuals with a family history of cone-rod dystrophy or those experiencing symptoms, as early detection can aid in managing the condition and planning for future healthcare needs.
The cost of the POC1B gene cone-rod dystrophy type 20 genetic test at DNA Labs UAE is 4400 AED. This investment allows individuals to gain valuable insights into their genetic makeup, providing an opportunity for early intervention and support for those affected by this form of dystrophy.
The ABCA4 gene cone-rod dystrophy type 3 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the ABCA4 gene that are associated with cone-rod dystrophy type 3, a rare genetic disorder. This condition primarily affects the retina, leading to the progressive loss of vision due to the degeneration of cone and rod photoreceptor cells. Symptoms often include decreased visual acuity, loss of color vision, and sensitivity to light, which can significantly impact the quality of life.
Priced at 4400 AED, the test is conducted through a comprehensive analysis of the patient's DNA, aiming to pinpoint specific genetic alterations within the ABCA4 gene. By identifying these mutations, healthcare providers can offer accurate diagnoses, allowing for better-informed decisions regarding treatment and management of the condition. Additionally, this test can be crucial for family planning purposes, offering at-risk couples insights into their likelihood of passing the condition onto their offspring.
Performed at the state-of-the-art facilities of DNA Labs UAE, the test ensures confidentiality, reliability, and accuracy, employing cutting-edge genetic sequencing technologies. The results from this test not only aid in the diagnosis but also contribute to ongoing research and understanding of cone-rod dystrophy type 3, potentially paving the way for future therapeutic advancements.
The PDE6C Gene Cone-Rod Dystrophy Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at detecting mutations in the PDE6C gene, which are associated with Cone-Rod Dystrophy Type 4 (CORD4). Cone-Rod Dystrophy is a group of inherited eye disorders that affect the light-sensitive cells of the retina, leading to progressive vision loss. The PDE6C gene plays a crucial role in the normal functioning of these cells, and mutations in this gene can disrupt vision by affecting the photoreceptor cells responsible for color vision and visual acuity.
This genetic test is essential for individuals with a family history of Cone-Rod Dystrophy or those experiencing symptoms of the disorder, such as decreased visual acuity, loss of color vision, and difficulty seeing in low light conditions. Early detection through genetic testing can aid in the understanding of the condition, guide management and treatment options, and provide valuable information for family planning.
At DNA Labs UAE, the test is conducted with state-of-the-art technology to ensure accurate and reliable results. The cost of the PDE6C Gene Cone-Rod Dystrophy Type 4 Genetic Test is 3200 AED, reflecting the specialized nature of the test and the advanced techniques employed in the analysis. Individuals undergoing this test can expect comprehensive support from the lab's team, including detailed explanations of the testing process and assistance in interpreting the results.
The PITPNM3 gene is associated with Cone-Rod Dystrophy Type 5 (CORD5), a rare genetic disorder that affects the retina and leads to progressive vision loss. The disorder primarily impacts the cone and rod photoreceptor cells in the eye, which are crucial for color vision, central vision, and low-light vision. Mutations in the PITPNM3 gene disrupt the normal function of these cells, leading to the symptoms of CORD5.
To diagnose this condition, genetic testing can be conducted to identify mutations in the PITPNM3 gene. DNA Labs UAE offers a specific genetic test for this purpose, providing a crucial diagnostic tool for individuals exhibiting symptoms of Cone-Rod Dystrophy Type 5 or those with a family history of the disorder. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of genetic mutations associated with the condition.
The cost of the PITPNM3 gene Cone-Rod Dystrophy Type 5 genetic test at DNA Labs UAE is 4400 AED. This investment can provide invaluable information for affected individuals and their families, enabling them to understand their condition better, consider their options for genetic counseling, and plan for any necessary adjustments to their lifestyle or healthcare management.
The RIMS1 Gene Cone-Rod Dystrophy Type 7 Genetic Test is a specialized diagnostic examination conducted at DNA Labs UAE, designed to detect mutations in the RIMS1 gene, which are implicated in the development of Cone-Rod Dystrophy Type 7 (CORD7). This rare genetic disorder affects the retina, leading to the progressive loss of vision starting with color vision and night vision, eventually advancing to a loss of peripheral vision and central vision. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify any genetic anomalies associated with this condition. Early detection through this genetic testing can aid in the management and understanding of the disease, allowing for better planning for the affected individuals and their families.
The ADAM9 gene is linked to a form of inherited eye disorder known as Cone-Rod Dystrophy Type 9 (CORD9), which affects the retina and leads to progressive vision loss. This condition is characterized by the deterioration of cone and rod photoreceptor cells in the eye, crucial for color vision and seeing in low light, respectively. Symptoms often start with difficulty seeing in dim light and can progress to a loss of central and color vision.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the ADAM9 gene, providing crucial information for diagnosing Cone-Rod Dystrophy Type 9. This test is pivotal for individuals with a family history of the condition or those experiencing symptoms, as it can confirm the diagnosis and inform about the progression and management of the disease.
The cost of the ADAM9 gene test at DNA Labs UAE is 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of mutations in the ADAM9 gene. The results from this test can help in understanding the risk of developing the condition, guide treatment options, and support decisions regarding family planning for those affected by or carriers of the mutation.
The C21orf2 gene plays a significant role in the health and functionality of the retina, particularly influencing the development of cone-rod dystrophy, a genetic disorder that affects the eyes. Cone-rod dystrophy is characterized by the progressive loss of vision, starting with the deterioration of cone cells (responsible for color vision and visual acuity) and followed by rod cells (which enable low-light vision). Mutations in the C21orf2 gene have been identified as a causative factor for this condition, making genetic testing a valuable tool for diagnosis and understanding the risk of inheritance.
DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the C21orf2 gene, providing essential information for individuals with a family history of cone-rod dystrophy or those experiencing symptoms related to the disorder. The test is a critical step in the diagnosis process, offering insights that can guide treatment and management decisions, as well as inform family planning considerations.
The cost of the C21orf2 gene-related cone-rod dystrophy genetic test at DNA Labs UAE is 4400 AED. This investment covers the collection of a DNA sample, usually through a blood draw or cheek swab, and its subsequent analysis in the laboratory. The process is designed to be as non-invasive and straightforward as possible, with results typically available within a few weeks. The outcome of the test can provide individuals and their healthcare providers with crucial information to better understand the condition, its progression, and potential interventions to manage symptoms and improve quality of life.
The GCNT2 gene cataract autosomal dominant genetic test is a specialized diagnostic tool designed to identify mutations in the GCNT2 gene, which are associated with a form of cataract inherited in an autosomal dominant manner. Cataracts, characterized by the clouding of the eye's lens, can lead to diminished vision and, if untreated, blindness. The specific mutations in the GCNT2 gene linked to this condition can result in an early onset of cataract development, distinguishing it from age-related cataracts.
This genetic test is crucial for families with a history of early cataract development, as it helps in the early detection and management of the condition. Early diagnosis can lead to timely interventions, potentially preserving vision and improving the quality of life for affected individuals. Moreover, understanding the genetic basis of the condition can provide valuable information for family planning and genetic counseling.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics, offering a comprehensive range of genetic testing services. The cost of the GCNT2 gene cataract autosomal dominant genetic test is 4400 AED. This price reflects the intricate processes involved in genetic analysis, including DNA extraction, amplification, and sequencing, which are necessary to accurately identify mutations in the GCNT2 gene.
By opting for this test at DNA Labs UAE, individuals and families gain access to state-of-the-art genetic testing technologies, expert interpretation of results, and personalized advice on managing and mitigating the risks associated with hereditary cataracts.
The "CRYBB3 Gene Cataract Autosomal Recessive Congenital Nuclear Type 2 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the CRYBB3 gene that are associated with the development of a specific type of cataract. This condition, known as autosomal recessive congenital nuclear cataract type 2, is characterized by the clouding of the eye's lens at birth or shortly thereafter, affecting vision. The test is critical for early diagnosis and management of the condition, facilitating personalized treatment plans and potentially preventing severe vision impairment.
The genetic test involves analyzing the patient's DNA to identify mutations in the CRYBB3 gene, which plays a crucial role in the development and maintenance of lens transparency in the eye. Identifying mutations in this gene can confirm the diagnosis and help in understanding the inheritance pattern within a family, offering insights into the risk for future offspring.
The cost of the test is set at 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this test represents a significant step forward in the early detection and management of congenital cataract conditions, offering hope and improved outcomes for affected individuals and their families.
